Nerve growth factor (NGF) is involved in the modulation of the neuro-endocrine-immune (NEI) system, whereas alterations in neuroplasticity and NEI homeostasis seem to play a role in the pathophysiology of major depressive disorder (MDD). Objective of the study was to investigate NGF levels variations in MDD patients during antidepressant treatment with duloxetine, a relatively newer SNRI.
NGF serum levels variations in major depressed patients receiving duloxetine / Martino, Matteo; Rocchi, Giulio; Escelsior, Andrea; Contini, Paola; Colicchio, Salvatore; de Berardis, Domenico; Amore, Mario; Fornaro, Pantaleo; Fornaro, Michele. - In: PSYCHONEUROENDOCRINOLOGY. - ISSN 0306-4530. - 38:9(2013), p. 1824-8. [10.1016/j.psyneuen.2013.02.009]
NGF serum levels variations in major depressed patients receiving duloxetine
Martino, Matteo;Fornaro, Michele
2013
Abstract
Nerve growth factor (NGF) is involved in the modulation of the neuro-endocrine-immune (NEI) system, whereas alterations in neuroplasticity and NEI homeostasis seem to play a role in the pathophysiology of major depressive disorder (MDD). Objective of the study was to investigate NGF levels variations in MDD patients during antidepressant treatment with duloxetine, a relatively newer SNRI.| File | Dimensione | Formato | |
|---|---|---|---|
|
Full-text FINALE.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
254.48 kB
Formato
Adobe PDF
|
254.48 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
